Rappaport Stephen A MD is categorized under Medical Research in Indianapolis, IN and active since 2004.
Rappaport Stephen A MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Stephen Rappaport at the company’s single location by writing to 9292 North Meridian St # 107, Indianapolis, Indiana IN 46260 or by phoning (317) 846-9792. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rappaport Stephen A MD |
| Contact Person: | Stephen Rappaport |
| Address: | 9292 North Meridian St # 107, Indianapolis, Indiana 46260 |
| Phone Number: | (317) 846-9792 |
| Website Address: | agewell.biz |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6211110 |
| Share This Business: |
Rappaport Stephen A MD was started in 2004 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Stephen Rappaport for inquiries that concern Rappaport Stephen A MD by calling the company number (317) 846-9792, as your correspondence is most welcome. Additionally, the physical location of the single location of Rappaport Stephen A MD can be found at the coordinates 39.92313,-86.15805 as well as the street address 9292 North Meridian St # 107 in Indianapolis, Indiana 46260.
For its online presence, you may visit Rappaport Stephen A MD’s website at agewell.biz and engage with its social media outlets through on Twitter and on Facebook.